Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 98.0819 USD 0.26%
Market Cap: 4.7B USD
Have any thoughts about
Axsome Therapeutics Inc?
Write Note

Axsome Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Axsome Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Axsome Therapeutics Inc
NASDAQ:AXSM
Cash from Investing Activities
-$610k
CAGR 3-Years
-89%
CAGR 5-Years
-98%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Investing Activities
-$18.5B
CAGR 3-Years
-18%
CAGR 5-Years
-48%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Investing Activities
-$22.5B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash from Investing Activities
-$3.8B
CAGR 3-Years
31%
CAGR 5-Years
-15%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Cash from Investing Activities
-$6.2B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Cash from Investing Activities
-$10.3B
CAGR 3-Years
-50%
CAGR 5-Years
-3%
CAGR 10-Years
-13%

See Also

What is Axsome Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
-610k USD

Based on the financial report for Jun 30, 2024, Axsome Therapeutics Inc's Cash from Investing Activities amounts to -610k USD.

What is Axsome Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-98%

Over the last year, the Cash from Investing Activities growth was -39%. The average annual Cash from Investing Activities growth rates for Axsome Therapeutics Inc have been -89% over the past three years , -98% over the past five years .

Back to Top